Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Rapid Tests Market

Veterinary Rapid Tests Market Trends

Report ID: GMI3455
Published Date: May 2023
Report Format: PDF

Download Free Sample

Veterinary Rapid Tests Market Trends

One of the major factors driving market expansion is the increasing prevalence of zoonotic diseases. About one billion cases of illness and millions of deaths are caused by zoonotic diseases. Over the last three decades, more than 30 new human pathogens have been discovered and out of them 75% of which originated in animals. The potential risk of zoonotic illnesses increases, leading to increased pet ownership around the world, and it can transfer from animals to humans via viruses, bacteria, fungus, or parasites. The risk of catching zoonotic infections is especially significant among small-scale livestock keepers in rural areas of rising Asian and African countries. Hence, occurrence of these zoonotic diseases in companion animals of veterinary rapid tests will propel the market growth during the forecast period.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for veterinary rapid tests was more than USD 740.9 million in 2022 and will register over USD 1.7 billion by 2032.

Veterinary rapid tests industry from the viral application will record massive growth by 2032 owing to increasing viral infection outbreaks in animals and the risk of viral infections in humans.

North America market for veterinary rapid tests is estimated to grow by 2032 due to factors like the presence of well-established veterinary medical infrastructure and ongoing technological advancements.

IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Heska Corporation, BioNote, Inc., MEGACOR Diagnostik GmbH, Swissavans AG, and Virbac are some of the leading companies in the global veterinary rapid tests industry.